Pacific Biosciences of California, Inc. (PACB) Reports Q4 Loss of $0.42

Pacific Biosciences of California, Inc. (NASDAQ: PACB) reported Q4 EPS of ($0.42), $0.08 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $12.5 million versus the consensus estimate of $10.34 million.

For earnings history and earnings-related data on Pacific Biosciences of California, Inc. (PACB) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist
• Carvana (CVNA) PT Lowered to $85 at RBC Capital